SMCI
New target, same side-eye
Super Micro is getting some love from JPMorgan, but not the kind that makes bulls start champagne-popping in the parking lot. Analyst Samik Chatterjee lifted his price target to $32 from $28 and pointed to better customer diversification, stronger margins, and healthier out-year estimates.
The good news is actually pretty good
The company’s fiscal third-quarter 2026 results gave the stock some fuel:
- Revenue came in at $10.2 billion, which was below Street expectations
- Gross margin hit 10.1%, handily beating estimates
- EPS landed at $0.84, also beating forecasts
- For Q4, Super Micro guided revenue to $11.0 billion to $12.5 billion and EPS to $0.65 to $0.79, both above JPMorgan’s estimates
That’s a nice combo for a company that’s been under a microscope. In other words, the AI demand story is still doing the heavy lifting, and the margin recovery is starting to look less like wishful thinking and more like an actual trend.
But the parade gets an umbrella
Here’s the part keeping JPMorgan from turning outright bullish: governance uncertainty, possible capital-raising costs, and good old-fashioned pricing pressure. Translation: the business is improving, but the risk list still reads like a bad airport delay screen.
For investors, the takeaway is simple. SMCI is showing real operating progress, and the stock even jumped to around $32 on the news, but the market is still asking the same question: can the company keep the AI growth engine humming without tripping over its own baggage?
Big picture: this is a stronger Super Micro, not a fully rehabilitated one — and Wall Street is treating it exactly that way.